tiprankstipranks
Advertisement
Advertisement
Standard BioTools Adopts New Executive Severance Protection Plans
PremiumCompany AnnouncementsStandard BioTools Adopts New Executive Severance Protection Plans
20d ago
Standard Biotools Faces Nasdaq Delisting Risk After Prolonged Sub-$1 Share Price
Premium
Company Announcements
Standard Biotools Faces Nasdaq Delisting Risk After Prolonged Sub-$1 Share Price
1M ago
Standard BioTools Highlights Improved Q1 2026 Results, Outlook
Premium
Company Announcements
Standard BioTools Highlights Improved Q1 2026 Results, Outlook
1M ago
Standard BioTools reports Q4 EPS 5c vs (9c) last year
PremiumThe FlyStandard BioTools reports Q4 EPS 5c vs (9c) last year
4M ago
Standard BioTools sees FY26 revenue $80M-$85M, consensus $79.73M
Premium
The Fly
Standard BioTools sees FY26 revenue $80M-$85M, consensus $79.73M
4M ago
Is LAB a Buy, Before Earnings?
Premium
Pre-Earnings
Is LAB a Buy, Before Earnings?
4M ago
Standard BioTools Inc. Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsStandard BioTools Inc. Reports Q3 2025 Financial Results
7M ago
Cautious Hold Rating for Standard BioTools Amid Economic Challenges and Uncertain Strategic Outlook
Premium
Ratings
Cautious Hold Rating for Standard BioTools Amid Economic Challenges and Uncertain Strategic Outlook
7M ago
Standard BioTools Implements Restructuring for Future Growth
Premium
Company Announcements
Standard BioTools Implements Restructuring for Future Growth
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100